A new weight loss drug that has helped patients lose up to 2.5 stone could be coming to the UK.
The results of an 18-month trial of tirzepatide, a weekly injection medication, has seen participants shed up to 15.7 percent of their body weight - a loss of 15.6kg or 2.5 stone. Patients given a placebo comparatively lost an average of 3.2kg.
Tirzepatide is set to be available in the UK, reports The Times. Its manufacturer Eli Lilly will seek approval from regulators for the medication to be used on obese patients with a weight-related condition such as obesity and diabetes.
